Eprosartan contraindications

Revision as of 14:58, 20 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Eprosartan}} {{CMG}}; {{AE}} {{SS}} ==Contraindications== TEVETEN® is contraindicated in patients who are hypersensitive to this product or any of its compo...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Eprosartan
TEVETEN® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Eprosartan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Contraindications

TEVETEN® is contraindicated in patients who are hypersensitive to this product or any of its components.

Do not co-administer aliskiren with TEVETEN in patients with diabetes (see PRECAUTIONS, Drug Interactions).[1]

References

  1. "TEVETEN (EPROSARTAN MESYLATE) TABLET [ABBOTT LABORATORIES]". Retrieved 20 February 2014.

Template:Angiotensin II receptor antagonists